Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BioCryst Pharmaceuticals Inc
SWB:BO1
BioCryst Pharmaceuticals Inc
SWB:BO1
Price:
7.78
EUR
-0.1%
Market Closed
Market Cap:
€1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioCryst Pharmaceuticals Inc
SWB:BO1
|
US |
|
Hargreaves Services PLC
LSE:HSP
|
UK |
|
R
|
Reflex Advanced Materials Corp
CNSX:RFLX
|
CA |
|
K
|
Koh Young Technology Inc
KOSDAQ:098460
|
KR |
|
K
|
Kbc Ancora NV
SWB:KB9
|
BE |
|
Meiko Network Japan Co Ltd
TSE:4668
|
JP |
|
B
|
BioCryst Pharmaceuticals Inc
F:BO1
|
US |
|
Fobi AI Inc
OTC:FOBIF
|
CA |
|
Sibanye Stillwater Ltd
OTC:SBYSF
|
ZA |
|
NDR Auto Components Ltd
NSE:NDRAUTO
|
IN |
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
A
|
Alfio Bardolla Training Group SpA
LSE:0DEF
|
IT |
|
S
|
Spark New Zealand Ltd
ASX:SPK
|
NZ |
|
J
|
Jetema Co Ltd
KOSDAQ:216080
|
KR |
|
Slam Corp
OTC:SLAMF
|
US |
|
S
|
Samil
KOSDAQ:032280
|
KR |
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
|
1
|
1CM Inc
F:IQ70
|
CA |
|
Morgan Advanced Materials PLC
F:MGJ
|
UK |
|
P
|
Perseus Mining Ltd
XMUN:P4Q
|
AU |
|
Valmet Corp
OTC:VLMTY
|
FI |
|
T
|
Toronto-Dominion Bank
F:TDB
|
CA |
|
Lemtech Holdings Co Ltd
TWSE:4912
|
CN |
|
S
|
Sodexo SA
DUS:SJ7
|
FR |
Wall St Price Targets
BO1 Price Forecast
Based on 12 analysts
Based on 12 analysts
+116% Upside
from
€7.78
today
BioCryst Pharmaceuticals Inc (BO1)’s 12-month stock price forecast through August 2027 has a consensus target of €16.83, implying 116% upside. The forecast is based on price targets from 12 Wall Street analysts.
BO1 Analyst Rating
No ratings yet
No ratings yet
BioCryst Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BO1's stock price target?
Price Target
16.83
EUR
16.83
EUR
According to Wall Street analysts, the average 1-year price target for BO1 is 16.83 EUR with a low forecast of 9.91 EUR and a high forecast of 29.96 EUR.
What is the Revenue forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
12%
12%
The compound annual growth rate for Operating Income over the next 8 years is 12%.
What is the Pre-Tax Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
-3%
-3%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -3%.
What is the Net Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.